Summit Therapeutics Yönetim
Yönetim kriter kontrolleri 2/4
Summit Therapeutics CEO'su Bob Duggan, Jul2022 tarihinde atandı, in görev süresi 2.33 yıldır. şirketin hisselerinin 74.81% doğrudan sahiptir ve bu hisselerin değeri $ 11.52B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 4.5 yıldır.
Anahtar bilgiler
Bob Duggan
İcra Kurulu Başkanı
n/a
Toplam tazminat
CEO maaş yüzdesi | n/a |
CEO görev süresi | 2.3yrs |
CEO sahipliği | 74.8% |
Yönetim ortalama görev süresi | 2.3yrs |
Yönetim Kurulu ortalama görev süresi | 4.5yrs |
Son yönetim güncellemeleri
Recent updates
Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry?
Nov 08Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market
Oct 04Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial
Sep 19Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Sep 09Summit Therapeutics May Have Further Upside From Here
Aug 03Summit Therapeutics Stock: Plunging Despite A Win?
May 31Summit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer
May 06Summit Therapeutics: A Strategic Analysis Of Ivonescimab's Progress
Jan 30We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely
Dec 29Summit Therapeutics slips on plans to terminate study for lead candidate
Oct 04Summit Therapeutics: Developing Antibiotics Is A Noble Cause But The Company Is Wise To Expand Its Portfolio
Aug 17Summit Therapeutics GAAP EPS of -$0.17, revenue of $0.23M
Aug 11Summit to explore additional trial for its bacteria-induced colon infection drug
Jul 14Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation
Apr 29Summit Therapeutics - Disappointing Data But Not An Outright Failure
Dec 23Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator
Jun 22Summit Therapeutics to join Russell 3000 Index
Jun 08CEO
Bob Duggan (80 yo)
2.3yrs
Görev süresi
Mr. Robert W. Duggan, also known as Bob, had been an Interim Principal Financial Officer at Summit Therapeutics Inc. since July 02, 2021. He served as the Co-Chief Executive Officer at Summit Therapeutics...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Co-CEO & Executive Chairman | 2.3yrs | Veri yok | 74.81% $ 11.5b | |
Co-CEO, President & Director | 2.3yrs | US$20.56m | 4.85% $ 746.6m | |
COO, CFO & Director | 1.1yrs | US$23.97m | 0.41% $ 63.1m | |
Co-Founder | no data | Veri yok | Veri yok | |
Chief Accounting Officer & Head of Finance | less than a year | Veri yok | 0.018% $ 2.7m | |
Head of Human Resources | 1.6yrs | Veri yok | Veri yok | |
Head of Global Clinical Operations | 4.7yrs | Veri yok | Veri yok | |
Chief Business & Strategy Officer | no data | Veri yok | Veri yok | |
Head of Research | 3.4yrs | Veri yok | Veri yok | |
Chief Biometrics Officer | 3.8yrs | Veri yok | Veri yok | |
Chief Education & Brand Officer | 1.8yrs | Veri yok | Veri yok | |
Head of Clinical Pharmacology & DMPK | 3.3yrs | Veri yok | Veri yok |
2.3yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim: SMMT 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Co-CEO & Executive Chairman | 4.9yrs | Veri yok | 74.81% $ 11.5b | |
Co-CEO, President & Director | 4yrs | US$20.56m | 4.85% $ 746.6m | |
COO, CFO & Director | 4.9yrs | US$23.97m | 0.41% $ 63.1m | |
Co-Founder | no data | Veri yok | Veri yok | |
Lead Independent Director | 3.1yrs | US$334.65k | 0% $ 0 | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory board | no data | Veri yok | Veri yok | |
Member of Scientific Advisory board | no data | Veri yok | Veri yok |
4.5yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SMMT 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.5 yıldır).